iPSC-based strategy to correct the bleeding phenotype in haemophilia A

被引：0
|
作者：
Talmon, M. [1 ]
Ranaldo, G. [1 ]
Olgasi, C. [1 ]
Lombardo, A. [2 ]
Merlin, S. [1 ]
Cannizzo, E. S. [1 ]
Raya, A. [3 ]
Naldini, L. [2 ]
Schinco, P. [4 ]
Follenzi, A. [1 ]
机构：
[1] Univ Piemonte Orientale, Novara, Italy
[2] H San Raffaele, Tiget, Milan, Italy
[3] Inst Bioengn Catalonia, Barcelona, Spain
[4] Az Osp Univ S Giovanni Battista Molinette, Turin, Italy
来源：
HUMAN GENE THERAPY | 2013年 / 24卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [1] IPSC-based strategy to correct the bleeding phenotype in haemophilia A
    Talmon, M.
    Ranaldo, G.
    Grosso, C.
    Cannizzo, E. S.
    Merlin, S.
    Lombardo, A.
    Raya, A.
    Naldini, L.
    Schinco, P.
    Follenzi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 71 - 72
  • [2] Novel iPSC-based strategy to correct the bleeding phenotype in haemophilia A
    Talmon, M.
    Olgasi, C.
    Merlin, S.
    Ranaldo, G.
    Lombardo, A.
    Naldini, L.
    Raya, A.
    Schinco, P.
    Messina, M.
    Follenzi, A.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 : 81 - 81
  • [3] A Novel iPSC-Based Strategy To Correct the Bleeding Phenotype in Hemophilia A
    Ranaldo, Gabriella
    Richaud-Patin, Yvonne
    Lombardo, Angelo
    Grosso, Chantal
    Talmon, Maria
    Raya, Angel
    Naldini, Luigi
    Schinco, Piercarla
    Follenzi, Antonia
    MOLECULAR THERAPY, 2012, 20 : S251 - S251
  • [4] iPSC-Based Strategy To Correct the Bleeding Phenotype in Hemophilia A Targeting FVIII Expression to Endothelial Cells
    Talmon, Maria
    Ranaldo, Gabriella
    Grosso, Chantal
    Lombardo, Angelo
    Merlin, Simone
    Cannizzo, Stefania E.
    Raya, Angel
    Naldini, Luigi
    Schinco, Piercarla
    Follenzi, Antonia
    MOLECULAR THERAPY, 2013, 21 : S180 - S180
  • [5] Induced pluripotent stem cell (IPSC) based strategy to correct the bleeding phenotype in hemophilia A
    Talmon, M.
    Olgasi, C.
    Merlin, S.
    Ranaldo, G.
    Lombardo, A.
    Colangelo, D.
    Berta, G. N.
    Naldini, L.
    Raya, A.
    Valeri, F.
    Schinco, P.
    Messina, M.
    Follenzi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 32 - 32
  • [6] Induced Pluripotent Stem Cell- (iPSC) based Strategy to Correct the Bleeding Phenotype in Hemophilia A
    Talmon, M.
    Olgasi, C.
    Merlin, S.
    Colangelo, D.
    Berta, G. N.
    Lombardo, A.
    Naldini, L.
    Raya, A.
    Schinco, P.
    Messina, M.
    Follenzi, A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A115 - A115
  • [7] Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype
    Macadangdang, Jesse
    Guan, Xuan
    Smith, Alec S. T.
    Lucero, Rachel
    Czerniecki, Stefan
    Childers, Martin K.
    Mack, David L.
    Kim, Deok-Ho
    CELLULAR AND MOLECULAR BIOENGINEERING, 2015, 8 (03) : 320 - 332
  • [8] Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype
    Jesse Macadangdang
    Xuan Guan
    Alec S. T. Smith
    Rachel Lucero
    Stefan Czerniecki
    Martin K. Childers
    David L. Mack
    Deok-Ho Kim
    Cellular and Molecular Bioengineering, 2015, 8 : 320 - 332
  • [9] An iPSC-Based Model Of MDS For Phenotype-Driven Gene and Drug Discovery
    Boussaad, Ibrahim
    Kotini, Andriana
    Dolezal, Emily K.
    Nimer, Stephen
    Papapetrou, Eirini P.
    BLOOD, 2013, 122 (21)
  • [10] Towards a personalized iPSC-based vaccine
    Cleo Goyvaerts
    Karine Breckpot
    Nature Biomedical Engineering, 2018, 2 : 277 - 278
12345